Principal Financial Group
ALXN

Principal Financial Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-285,699
Closed -$52.5M 2655
2021
Q2
$52.5M Buy
285,699
+6,851
+2% +$1.26M 0.03% 421
2021
Q1
$42.6M Sell
278,848
-14,526
-5% -$2.22M 0.03% 486
2020
Q4
$45.8M Sell
293,374
-17,235
-6% -$2.69M 0.03% 406
2020
Q3
$35.5M Sell
310,609
-20,692
-6% -$2.37M 0.03% 452
2020
Q2
$37.2M Buy
331,301
+17,353
+6% +$1.95M 0.03% 424
2020
Q1
$28.2M Buy
313,948
+271
+0.1% +$24.3K 0.03% 439
2019
Q4
$33.9M Sell
313,677
-25,354
-7% -$2.74M 0.03% 517
2019
Q3
$33.2M Sell
339,031
-1,892
-0.6% -$185K 0.03% 505
2019
Q2
$44.7M Buy
340,923
+13,718
+4% +$1.8M 0.04% 418
2019
Q1
$44.2M Sell
327,205
-1,039
-0.3% -$140K 0.04% 426
2018
Q4
$32M Sell
328,244
-4,048
-1% -$394K 0.03% 484
2018
Q3
$46.2M Buy
332,292
+6,396
+2% +$889K 0.04% 443
2018
Q2
$40.5M Buy
325,896
+1,072
+0.3% +$133K 0.04% 461
2018
Q1
$36.2M Sell
324,824
-4,307
-1% -$480K 0.03% 502
2017
Q4
$39.4M Buy
329,131
+6,017
+2% +$720K 0.04% 485
2017
Q3
$45.3M Sell
323,114
-12,411
-4% -$1.74M 0.04% 435
2017
Q2
$40.8M Buy
335,525
+4,115
+1% +$501K 0.04% 464
2017
Q1
$40.2M Buy
331,410
+5,137
+2% +$623K 0.05% 402
2016
Q4
$39.9M Sell
326,273
-1,546
-0.5% -$189K 0.05% 380
2016
Q3
$40.2M Buy
327,819
+7,006
+2% +$859K 0.05% 361
2016
Q2
$37.5M Sell
320,813
-1,368
-0.4% -$160K 0.05% 338
2016
Q1
$44.9M Buy
322,181
+5,471
+2% +$762K 0.07% 287
2015
Q4
$60.4M Buy
316,710
+7,145
+2% +$1.36M 0.09% 240
2015
Q3
$48.4M Buy
309,565
+13,574
+5% +$2.12M 0.08% 274
2015
Q2
$53.5M Buy
295,991
+29,788
+11% +$5.38M 0.08% 265
2015
Q1
$46.1M Buy
266,203
+8,490
+3% +$1.47M 0.07% 291
2014
Q4
$47.7M Buy
257,713
+9,622
+4% +$1.78M 0.07% 280
2014
Q3
$41.1M Buy
248,091
+4,072
+2% +$675K 0.07% 294
2014
Q2
$38.1M Sell
244,019
-19,548
-7% -$3.05M 0.06% 321
2014
Q1
$40.1M Buy
263,567
+8,373
+3% +$1.27M 0.07% 312
2013
Q4
$34M Buy
255,194
+1,487
+0.6% +$198K 0.06% 340
2013
Q3
$29.5M Buy
253,707
+854
+0.3% +$99.2K 0.06% 342
2013
Q2
$23.3M Buy
+252,853
New +$23.3M 0.05% 379